Tumor Marker Test Kits in this report.
This report contains market size and forecasts of Rapid Tumor Marker Tests in global, including the following market information:
Global Rapid Tumor Marker Tests Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Rapid Tumor Marker Tests Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Rapid Tumor Marker Tests companies in 2021 (%)
The global Rapid Tumor Marker Tests market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Blood Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rapid Tumor Marker Tests include Biomerieux, Labcorp, JOYSBIO, Fujirebio, GRAIL, Randox, Wondfo Biotech, Orient Gene and Hangzhou Biotest, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rapid Tumor Marker Tests manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rapid Tumor Marker Tests Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rapid Tumor Marker Tests Market Segment Percentages, by Type, 2021 (%)
Blood Testing
Urine Testing
Body Tissue Testing
Others
Global Rapid Tumor Marker Tests Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rapid Tumor Marker Tests Market Segment Percentages, by Application, 2021 (%)
Lung Cancer
Breast Cancer
Stomach Cancer
Liver Cancer
Esophageal Cancer
Others
Global Rapid Tumor Marker Tests Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rapid Tumor Marker Tests Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rapid Tumor Marker Tests revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Rapid Tumor Marker Tests revenues share in global market, 2021 (%)
Key companies Rapid Tumor Marker Tests sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Rapid Tumor Marker Tests sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biomerieux
Labcorp
JOYSBIO
Fujirebio
GRAIL
Randox
Wondfo Biotech
Orient Gene
Hangzhou Biotest
Assure Tech
Aotai Bio
Wantai BioPharm
Bioneovan